H.R. 9598 · 118th Congress
Office of National Drug Control Policy Reauthorization Act of 2024
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
5 cosponsors · 3 D, 2 R
5 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- House Introduced Sep 16, 2024
- House Passed Dec 5, 2024 399–1
Office of National Drug Control Policy Reauthorization Act of 2024
What it does: CRS summary · Introduced in House · Sep 16, 2024
Office of National Drug Control Policy Reauthorization Act of 2024
This bill reauthorizes through FY2031 the Office of National Drug Control Policy and related grants, programs, and initiatives such as
- the High Intensity Drug Trafficking Areas program,
- the Drug-Free Communities program,
- the Drug Court Training and Technical Assistance program, and
- the National Community Anti-Drug Coalition Institute.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
Votes to become law
About this bill and sources
Official title: Office of National Drug Control Policy Reauthorization Act of 2024
Latest action (Dec 9, 2024): Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Policy area: Crime and Law Enforcement · Origin: House · Introduced: Sep 16, 2024
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML) · Embed in your story
- House Introduced Sep 16, 2024
- House Passed Dec 5, 2024 399–1
Final vote · House · Dec 5, 2024
Passage (two-thirds required) — Passed. Vote details
Speaker of the House: Mike Johnson